Edition:
United Kingdom

Akorn Inc (AKRX.OQ)

AKRX.OQ on NASDAQ Stock Exchange Global Select Market

30.12USD
23 Feb 2018
Change (% chg)

$-0.61 (-1.99%)
Prev Close
$30.73
Open
$30.89
Day's High
$30.97
Day's Low
$29.45
Volume
523,301
Avg. Vol
451,792
52-wk High
$33.99
52-wk Low
$20.00

Select another date:

Tue, Dec 19 2017

REFILE-Fresenius now sees completion of Akorn takeover in early 2018

FRANKFURT, Dec 19 Fresenius now expects its planned takeover of Akorn, a U.S. maker of liquid generic drugs, to be completed in early 2018 rather than this year, a spokesman for Fresenius said on Tuesday.

Fresenius says Akorn deal closure could take until next year

FRANKFURT German healthcare group Fresenius SE said the planned takeover of Akorn , a U.S. maker of liquid generic drugs, might not be completed before next year as the U.S. antitrust review could take longer than expected.

Fresenius says Akorn deal closure could take until next year

FRANKFURT, Nov 22 German healthcare group Fresenius SE said the planned takeover of Akorn , a U.S. maker of liquid generic drugs, might not be completed before next year as the U.S. antitrust review could take longer than expected.

UPDATE 1-Fresenius says Akorn troubles could continue into next year

FRANKFURT, Nov 2 German healthcare group Fresenius SE said on Thursday that weakness at Akorn , the U.S. maker of liquid generic drugs it has agreed to buy, could continue into next year but the deal was still worth it over the longer term.

Insys founder Kapoor steps down as Akorn chairman after arrest

NEW YORK John Kapoor, the billionaire founder of opioid maker Insys Therapeutics Inc, has resigned as chairman of drugmaker Akorn Inc, just days after his arrest on charges he participated in a scheme to bribe doctors to prescribe a potent pain medication while he was at Insys.

Insys founder Kapoor steps down as Akorn chairman after arrest

NEW YORK, Oct 31 John Kapoor, the billionaire founder of opioid maker Insys Therapeutics Inc, has resigned as chairman of drugmaker Akorn Inc, just days after his arrest on charges he participated in a scheme to bribe doctors to prescribe a potent pain medication while he was at Insys.

Senvest Management shorting drug stocks Insys, Akorn, Fresenius

TEL AVIV, Oct 3 New York-based Senvest Management is shorting three drug stocks, Insys Therapeutics Inc , Akorn Inc and Fresenius SE, its chief executive Richard Mashaal said on Tuesday,

Select another date: